Option Care Health, Inc. (NASDAQ:OPCH) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have received a consensus rating of “Moderate Buy” from the six research firms that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $30.83.

Several equities analysts have commented on the stock. Truist Financial decreased their price objective on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Barrington Research reduced their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Finally, The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the company from $38.00 to $27.00 in a research note on Monday, November 4th.

Option Care Health Stock Down 2.0 %

OPCH stock opened at $22.48 on Monday. Option Care Health has a 1-year low of $22.25 and a 1-year high of $34.63. The business’s 50 day simple moving average is $29.80 and its 200 day simple moving average is $29.70. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $3.83 billion, a PE ratio of 18.89, a PEG ratio of 2.43 and a beta of 1.32.

Insider Activity

In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now owns 247,317 shares of the company’s stock, valued at $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

Hedge funds have recently made changes to their positions in the company. Connor Clark & Lunn Investment Management Ltd. raised its position in Option Care Health by 438.7% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 145,257 shares of the company’s stock worth $4,547,000 after purchasing an additional 118,292 shares during the last quarter. Global Alpha Capital Management Ltd. lifted its stake in shares of Option Care Health by 108.3% in the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock valued at $1,559,000 after purchasing an additional 25,905 shares during the period. Jennison Associates LLC boosted its position in shares of Option Care Health by 26.6% during the 3rd quarter. Jennison Associates LLC now owns 472,274 shares of the company’s stock valued at $14,782,000 after purchasing an additional 99,139 shares in the last quarter. Avior Wealth Management LLC boosted its position in shares of Option Care Health by 11.2% during the 3rd quarter. Avior Wealth Management LLC now owns 24,300 shares of the company’s stock valued at $761,000 after purchasing an additional 2,442 shares in the last quarter. Finally, Pathstone Holdings LLC grew its stake in Option Care Health by 9.8% during the third quarter. Pathstone Holdings LLC now owns 68,895 shares of the company’s stock worth $2,156,000 after purchasing an additional 6,134 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.